Current Therapy of Type 2 Diabetes Mellitus using a Sample of SulfonylureaG — Prolonged Releasing Gliclazide Produced by Pharmak, Ltd (Kyiv, Ukraine)
Journal Title: Міжнародний ендокринологічний журнал - Year 2015, Vol 2, Issue 66
Abstract
The paper describes the efficacy of sulfonylurea derivative — domestic medication Dіaglizide MR (Farmak, Ltd) in the treatment of type 2 diabetes mellitus. The efficacy and safety of the agent confirmed in scientific studies allow recommend it for the treatment of type 2 diabetes mellitus.
Authors and Affiliations
O. Yu. Mykhailenko
Keywords
Related Articles
- EP ID EP222658
- DOI -
- Views 53
- Downloads 0
Features of lymphocyte phenotyping in patients with activated recurrent herpetic infection of the first/second type and reproductive system disorders
The aim of the study was an analysis of the features of changes in lymphocyte subpopulation according to the data of immunography in patients with a recrudescent herpetic infection and reproductive violations. Materials...
Assessment of Glycemia Impact on the Parameters of Sleep in Type 1 Diabetes Mellitus: the Results of Cross-Sectional Cohort Trial
This study demonstrates the impact of glycemia according to daily monitoring of blood glucose on parameters of nocturnal sleep in type 1 diabetic patients, regardless of the glycated haemoglobin level.
Rational Pharmacotherapy of Endocrine Diseases
.
Quality of Life in Patients with Diabetes Mellitus Type 2 with Metabolic Neuropathy against Pathogenic Therapy
Quality of Life in Patients with Diabetes Mellitus Type 2 with Metabolic Neuropathy against Pathogenic Therapy
Glimepiride (Amaryl®) in the Treatment of Patients with Diabetes Mellitus Type 2 (Pathophysiological Rationale and Clinical Implementation)
The article provides an overview of data on the clinical efficacy of glimepiride (Amaryl®) in diabetes mellitus type 2: there are described the effect of glimepiride on insulin resistance, body weight, its antiatherogeni...